Assignee
Prilenia Neurotherapeutics Ltd
IL·19 granted patents·30 pending applications·17 citations·filing 2016–2025
Top patents by PatentIndex Score
49 records- 0188US11141412B2Analogs of pridopidine, their preparation and usePrilenia Neurotherapeutics Ltd·Filed 2019·Granted Oct 12, 2021·3 cites·26 claims
- 0285US10406145B2Analogs of pridopidine, their preparation and usePrilenia Neurotherapeutics Ltd·Filed 2018·Granted Sep 10, 2019·5 cites·24 claims
- 0384US11406625B2Method of treating amyotrophic lateral sclerosis with pridopidinePrilenia Neurotherapeutics Ltd·Filed 2020·Granted Aug 9, 2022·2 cites·15 claims
- 0484US10603311B2Use of pridopidine to improve cognitive function and for treating Alzheimer's diseasePrilenia Neurotherapeutics Ltd·Filed 2016·Granted Mar 31, 2020·4 cites·12 claims
- 0583US12102627B2Use of pridopidine for treating rett syndromePrilenia Neurotherapeutics Ltd·Filed 2020·Granted Oct 1, 2024·1 cites·25 claims
- 0678US2025360121A1Pridopidine for treating huntington's diseasePrilenia Neurotherapeutics Ltd·Filed 2025·Application pending·0 cites
- 0777US2024041855A1Modified release formulations of pridopidinePrilenia Neurotherapeutics Ltd·Filed 2023·Application pending·0 cites
- 0876US11452694B2High concentration dosage forms of pridopidinePrilenia Neurotherapeutics Ltd·Filed 2020·Granted Sep 27, 2022·1 cites·26 claims
- 0974US11738012B2Treatment of neurodegenerative eye disease using pridopidinePrilenia Neurotherapeutics Ltd·Filed 2017·Granted Aug 29, 2023·1 cites·42 claims
- 1071US10799492B2Deuterated analogs of pridopidine useful as dopaminergic stabilizersPrilenia Neurotherapeutics Ltd·Filed 2018·Granted Oct 13, 2020·0 cites·3 claims
- 1171US2022023280A1Analogs of pridopidine, their preparation and usePrilenia Neurotherapeutics Ltd·Filed 2021·Application pending·0 cites
- 1271US2024398778A1Use of pridopidine for treating rett syndromePrilenia Neurotherapeutics Ltd·Filed 2024·Application pending·0 cites
- 1370US2024050423A1Use of pridopidine for the treatment of anxiety and depressionPrilenia Neurotherapeutics Ltd·Filed 2023·Application pending·0 cites
- 1469US12564582B2Use of pridopidine for treating dystoniasPrilenia Neurotherapeutics Ltd·Filed 2023·Granted Mar 3, 2026·0 cites·23 claims
- 1567US11000519B2Pridopidine for treating drug induced dyskinesiasPrilenia Neurotherapeutics Ltd·Filed 2019·Granted May 11, 2021·0 cites·20 claims
- 1666US12551474B2Use of pridopidine for the treatment of fragile X syndromePrilenia Neurotherapeutics Ltd·Filed 2022·Granted Feb 17, 2026·0 cites·10 claims
- 1766US12390456B2Pridopidine for treating Huntington's diseasePrilenia Neurotherapeutics Ltd·Filed 2021·Granted Aug 19, 2025·0 cites·9 claims
- 1866US2025082619A1Use of pridopidine for treating functional declinePrilenia Neurotherapeutics Ltd·Filed 2024·Application pending·0 cites
- 1966US2023181548A1Use of pridopidine for treating functional declinePrilenia Neurotherapeutics Ltd·Filed 2023·Application pending·0 cites
- 2064US2025250233A1Processes and intermediates for the preparation of pridopidinePrilenia Neurotherapeutics Ltd·Filed 2023·Application pending·0 cites
- 2164US2025235441A1Use of pridopidine for the treatment of anxiety and depressionPrilenia Neurotherapeutics Ltd·Filed 2025·Application pending·0 cites
- 2264US2024148708A1Method of treating amyotrophic lateral sclerosis with pridopidinePrilenia Neurotherapeutics Ltd·Filed 2024·Application pending·0 cites
- 2362US2026091028A1Method of treating amyotrophic lateral sclerosis with pridopidinePrilenia Neurotherapeutics Ltd·Filed 2025·Application pending·0 cites
- 2462US2023330073A1Use of pridopidine for treating functional declinePrilenia Neurotherapeutics Ltd·Filed 2023·Application pending·0 cites
- 2562US2024261273A1Pridopidine and analogs thereof for the treatment of neurodegenerative eye diseasePrilenia Neurotherapeutics Ltd·Filed 2024·Application pending·0 cites
- 2662US2023355595A1Use of pridopidine for treating functional declinePrilenia Neurotherapeutics Ltd·Filed 2023·Application pending·0 cites
- 2760US12036213B2Pridopidine for treating drug induced dyskinesiasPrilenia Neurotherapeutics Ltd·Filed 2021·Granted Jul 16, 2024·0 cites·29 claims
- 2860US2026060967A1Use of pridopidine for treating huntington diseasePrilenia Neurotherapeutics Ltd·Filed 2025·Application pending·0 cites
- 2960US2021220342A1Pridopidine for the treatment of mitochondrial-associated diseases and disorders and endoplasmic reticulum (er) stressPrilenia Neurotherapeutics Ltd·Filed 2021·Application pending·0 cites
- 3059US2025221972A1Pridopidine for the treatment of mitochondrial-associated diseases and disordersPrilenia Neurotherapeutics Ltd·Filed 2025·Application pending·0 cites
- 3159US2023190724A1Method of treating amyotrophic lateral sclerosis with pridopidinePrilenia Neurotherapeutics Ltd·Filed 2023·Application pending·0 cites
- 3258US2026034109A1Method of treating amyotrophic lateral sclerosis with pridopidinePrilenia Neurotherapeutics Ltd·Filed 2025·Application pending·0 cites
- 3358US2023100072A1Treatment of viral infection, disease or disorder using a selective s1r agonistPrilenia Neurotherapeutics Ltd·Filed 2022·Application pending·0 cites
- 3458US2025352533A1Pridopidine for treating huntington's diseasePrilenia Neurotherapeutics Ltd·Filed 2025·Application pending·0 cites
- 3558US2023112948A1Use of pridopidine for treating anxiety and depressionPrilenia Neurotherapeutics Ltd·Filed 2022·Application pending·0 cites
- 3658US2021052560A1Use of pridopidine for treating functional declinePrilenia Neurotherapeutics Ltd·Filed 2020·Application pending·0 cites
- 3757US2021093622A1Use of pridopidine for the treatment of anxiety and depressionPrilenia Neurotherapeutics Ltd·Filed 2020·Application pending·0 cites
- 3856US2023414596A1Use of pridopidine and analogs for treating rett syndromePrilenia Neurotherapeutics Ltd·Filed 2021·Application pending·0 cites
- 3956US2024197708A1Treatment of prodromal huntington diseasePrilenia Neurotherapeutics Ltd·Filed 2022·Application pending·0 cites
- 4055US11090297B2Pridopidine for treating huntington's diseasePrilenia Neurotherapeutics Ltd·Filed 2019·Granted Aug 17, 2021·0 cites·2 claims
- 4155US2023390272A1Use of pridopidine and analogs for the treatment of anxiety and depressionPrilenia Neurotherapeutics Ltd·Filed 2021·Application pending·0 cites
- 4255US2025319076A1Use of pridopidine and analogs for treating symptoms of huntington diseasePrilenia Neurotherapeutics Ltd·Filed 2025·Application pending·0 cites
- 4353US2022062255A1Treatment of neurodegenerative eye disease using pridopidinePrilenia Neurotherapeutics Ltd·Filed 2021·Application pending·0 cites
- 4452US11471449B2Use of pridopidine to improve cognitive function and for treating Alzheimer's diseasePrilenia Neurotherapeutics Ltd·Filed 2019·Granted Oct 18, 2022·0 cites·17 claims
- 4552US11234973B2Use of pridopidine for the treatment of fragile X syndromePrilenia Neurotherapeutics Ltd·Filed 2019·Granted Feb 1, 2022·0 cites·17 claims
- 4651US11207308B2Pharmaceutical compositions for combination therapyPrilenia Neurotherapeutics Ltd·Filed 2018·Granted Dec 28, 2021·0 cites·36 claims
- 4751US2021030734A1Method of treating amyotrophic lateral sclerosis with pridopidinePrilenia Neurotherapeutics Ltd·Filed 2020·Application pending·0 cites
- 4848US12357624B2Low dose pridopidine for Parkinson's Disease and other diseases associated with parkinsonismPrilenia Neurotherapeutics Ltd·Filed 2020·Granted Jul 15, 2025·0 cites·21 claims
- 4937US11207310B2Use of pridopidine for treating functional declinePrilenia Neurotherapeutics Ltd·Filed 2017·Granted Dec 28, 2021·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Prilenia Neurotherapeutics Ltd files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →